Skip to main content

Table 4 Multivariate analysis of Clinicopathological features, tumor markers, and patient survival

From: Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy

Variable

PFS HR (95% CI)

P value

OS HR (95% CI)

P value

ERCC1 (positive vs. negative)

0.427 (0.211-0.864)

0.018*

0.447 (0.219-0.911)

0.027*

BAG-1 (positive vs. negative)

0.474 (0.257-0.874)

0.017*

0.486 (0.262-0.901)

0.022*

Metastasis lymphatics (Yes vs. No)

0.627 (0.299-1.315)

0.217

0.654 (0.352-1.370)

0.260

TNM stage (I + II vs. III + IV)

0.699 (0.336-1.457)

0.340

1.442 (0.691-2.984)

0.324

  1. * represent P < 0.05